Position in XLO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,230,726
+$760,955 QoQ
Shares Held
650,389
0.0% QoQ
Ownership
11.2%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#2
of 26 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GILEAD SCIENCES, INC. holds $1,649,480,361 across 5 Biotechnology names. XLO ranks #5 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RCUS |
Arcus Biosciences, Inc.
|
31,424,760 | $968,825,350 | |
| 2 | LKFT |
Lakefront Biotherapeutics NV
|
16,707,477 | $500,890,160 | |
| 3 | ASMB |
Assembly Biosciences, Inc.
|
4,977,089 | $136,770,405 | |
| 4 | KYTX |
Kyverna Therapeutics, Inc.
|
4,126,119 | $36,763,720 | |
| 5 | XLO |
Xilio Therapeutics, Inc.
This page
|
650,389 | $6,230,726 |
All Filings in XLO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,230,726 | 650,389 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $5,469,771 | 650,389 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,827,488 | 9,105,451 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,675,895 | 9,105,451 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,191,706 | 9,105,451 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,592,346 | 9,105,451 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,695,705 | 9,105,451 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||